Kandu

Kandu is a neurotechnology company dedicated to enhancing stroke recovery through innovative brain-computer interface technology and personalized telehealth services. Formed from the merger of Neurolutions and Kandu Health in 2025, Kandu focuses on providing accessible, home-based recovery solutions for stroke survivors and their care partners. The company is led by CEO Dr. Leo Petrossian, who brings extensive experience in medical device commercialization. Kandu offers the IpsiHand® device, an FDA-cleared brain-computer interface that helps restore hand and arm function using signals from the unaffected side of the brain. Additionally, Kandu provides telehealth services that include personalized support, customized recovery plans, and health monitoring through an app. This integrated approach combines advanced technology with clinical expertise and community support, ensuring comprehensive care for stroke survivors. Kandu collaborates with healthcare providers and institutions to enhance post-acute care and is involved in ongoing research related to stroke detection and rehabilitation.